Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:BABYF NASDAQ:MODD OTCMKTS:MRMD NASDAQ:NEPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBABYFElse Nutrn$0.04-2.5%$0.02$0.01▼$0.11$14.59M1.34288,263 shs287,615 shsMODDModular Medical$0.75+2.0%$0.75$0.63▼$2.65$40.63M0.1795,234 shs167,335 shsMRMDMariMed$0.10+1.0%$0.09$0.07▼$0.29$38.07M3.02447,868 shs389,204 shsNEPHNephros$3.90+34.9%$3.69$1.36▼$5.00$41.34M1.1126,601 shs150,623 shs10 Stocks Set to Soar in Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBABYFElse Nutrn0.00%+11.43%+174.65%+257.80%-52.44%MODDModular Medical0.00%+4.76%+0.13%-25.10%-51.68%MRMDMariMed0.00%0.00%-5.89%+2.63%-42.38%NEPHNephros0.00%+14.07%+4.00%+105.26%+82.24%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBABYFElse NutrnN/AN/AN/AN/AN/AN/AN/AN/AMODDModular Medical0.421 of 5 stars0.04.00.00.00.61.70.0MRMDMariMed0.7632 of 5 stars0.03.00.00.02.50.80.6NEPHNephros2.3532 of 5 stars3.53.00.00.03.40.80.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBABYFElse Nutrn 0.00N/AN/AN/AMODDModular Medical 0.00N/AN/AN/AMRMDMariMed 4.00Strong BuyN/AN/ANEPHNephros 3.00Buy$5.5041.03% UpsideCurrent Analyst Ratings BreakdownLatest BABYF, MODD, MRMD, and NEPH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/8/2025NEPHNephrosMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$4.50 ➝ $6.00(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBABYFElse Nutrn$5.82M2.51N/AN/A$0.01 per share3.90MODDModular MedicalN/AN/AN/AN/A$0.42 per shareN/AMRMDMariMed$157.96M0.24$0.02 per share4.52$0.16 per share0.61NEPHNephros$14.16M2.92$0.02 per share194.89$0.81 per share4.81Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBABYFElse Nutrn-$11.08M-$0.11N/A∞N/A-193.36%-524.97%-142.29%N/AMODDModular Medical-$18.82M-$0.51N/A∞N/AN/A-178.13%-151.42%8/12/2025 (Estimated)MRMDMariMed-$12.16M-$0.03N/A∞N/A-10.14%-10.35%-3.08%N/ANEPHNephros$70K$0.0732.50∞N/A7.95%15.28%11.93%N/ALatest BABYF, MODD, MRMD, and NEPH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025NEPHNephros-$0.0250$0.02+$0.0450$0.02$3.60 million$4.40 million6/20/2025Q4 2025MODDModular Medical-$0.11-$0.12-$0.01-$0.12N/AN/A6/2/2025Q4 2024BABYFElse NutrnN/A-$0.02N/A-$0.02N/A$1.02 million5/15/2025Q1 2025NEPHNephros-$0.0050$0.0526+$0.0576$0.05$3.67 million$4.88 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBABYFElse NutrnN/AN/AN/AN/AN/AMODDModular MedicalN/AN/AN/AN/AN/AMRMDMariMedN/AN/AN/AN/AN/ANEPHNephrosN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBABYFElse NutrnN/A1.180.30MODDModular MedicalN/A10.6910.69MRMDMariMed1.211.050.37NEPHNephrosN/A5.924.64Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBABYFElse NutrnN/AMODDModular Medical27.47%MRMDMariMed0.18%NEPHNephros41.10%Insider OwnershipCompanyInsider OwnershipBABYFElse NutrnN/AMODDModular Medical20.46%MRMDMariMed18.99%NEPHNephros6.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBABYFElse Nutrn32374.11 millionN/ANot OptionableMODDModular Medical2054.25 million43.15 millionNot OptionableMRMDMariMed260390.43 million316.29 millionNot OptionableNEPHNephros3010.60 million9.89 millionNot OptionableBABYF, MODD, MRMD, and NEPH HeadlinesRecent News About These CompaniesNephros Inc (NEPH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Profitability ...August 9 at 4:10 AM | finance.yahoo.com�Nephros Announces Strong Second Quarter Financial ResultsAugust 7 at 4:00 PM | prismmediawire.comPNephros Announces Strong Second Quarter Financial ResultsAugust 7 at 4:00 PM | globenewswire.com�Nephros Schedules Second Quarter 2025 Financial Results Conference CallJuly 31, 2025 | prismmediawire.comPNephros Schedules Second Quarter 2025 Financial Results Conference CallJuly 31, 2025 | globenewswire.comNephros Inc. (NEPH) Stock Price Today - WSJJuly 4, 2025 | wsj.comJune 2025's Promising Penny Stocks With Growth PotentialJune 23, 2025 | finance.yahoo.comNephros, Inc. (NASDAQ:NEPH) Shares Could Be 37% Below Their Intrinsic Value EstimateJune 23, 2025 | uk.finance.yahoo.comNephros to Host Analyst and Investor Virtual EventMay 30, 2025 | finance.yahoo.comNephros First Quarter 2025 Earnings: Beats ExpectationsMay 10, 2025 | finance.yahoo.comNephros’s new microfilter offers enhanced installation flexibility for bacterial retentionApril 30, 2025 | filtsep.comFNephros Schedules First Quarter 2025 Financial Results Conference CallApril 30, 2025 | finance.yahoo.comNephros expands filtration line with new S100 In-Line filterApril 29, 2025 | investing.comNephros Launches New S100 In-Line MicrofilterApril 28, 2025 | finance.yahoo.comNephros Full Year 2024 Earnings: Beats ExpectationsMarch 28, 2025 | finance.yahoo.comEQS-News: Nephros Announces Fourth Quarter and Fiscal Year 2024 Financial ResultsMarch 8, 2025 | markets.businessinsider.comNephros Announces Fourth Quarter and Fiscal Year 2024 Financial ResultsMarch 7, 2025 | theglobeandmail.comNephros Amends CFO Employment Terms for Strategic GrowthMarch 4, 2025 | tipranks.comNephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2024 Financial ResultsFebruary 26, 2025 | finance.yahoo.comPleasing Signs As A Number Of Insiders Buy Nephros StockFebruary 26, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBABYF, MODD, MRMD, and NEPH Company DescriptionsElse Nutrn OTCMKTS:BABYF$0.04 0.00 (-2.50%) As of 08/8/2025 03:51 PM EasternElse Nutrition Holdings Inc. focuses on the research, development, manufacturing, marketing, and sale of plant-based food and nutrition products for infants, toddlers, children's, and adults in North America, Israel, Australia, and New Zealand. It offers baby and toddler snacks; baby feeding accessories, such as feeding bottles and teats; plant-based baby and toddler nutrition formula products; kids and adult nutrition products; and complementary food products for babies, as well as toddler drink for toddlers ages 12-36 months; and follow-on formula for infants. The company provides its products through online. Else Nutrition Holdings Inc. was founded in 2012 and is headquartered in Tel Aviv, Israel.Modular Medical NASDAQ:MODD$0.75 +0.01 (+2.03%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$0.76 +0.01 (+0.80%) As of 08/8/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.MariMed OTCMKTS:MRMD$0.10 +0.00 (+1.04%) As of 08/8/2025 03:51 PM EasternMariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.Nephros NASDAQ:NEPH$3.90 +1.01 (+34.95%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$3.80 -0.10 (-2.56%) As of 08/8/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/04 - 08/08 Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact? Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
